Home - Gastroenterology Advisor
While HIPAA rules protect health information of patients in hospitals and for physician visits, generally they do not protect the privacy or security of a patient’s health and wellness information when it is created accessed through or stored on personal cell …
Clinician Insights on How to Manage Semaglutide-Induced …
Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
FDA Says Shortage of GLP-1 Tirzepatide Is Over
5 days ago · Compounding pharmacies must now cease producing their own versions of Zepbound/Mounjaro within a set time period. HealthDay News — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is ...
What We Know About Semaglutide Adverse Events and …
Sep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Gastroparesis Awareness Month: Updated Guidelines to Treat …
Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
Recommendations Issued for Managing Chronic Constipation
Sep 24, 2024 · HealthDay News — Recommendations have been developed to address evaluation and management of chronic constipation, according to updated American Society of Colon and Rectal Surgeons guidelines published in the October issue of Diseases of the Colon & Rectum.. Karim Alavi, M.D., M.P.H., from UMass Memorial Medical Center in Worcester, Massachusetts, and colleagues developed guidelines for ...
GERD and the Elderly Patient: Clinical Considerations
Jan 7, 2020 · Patients with gastroesophageal reflux disease (GERD) are frequently referred to gastroenterologists. As patients get older GERD is more common, with a prevalence of 20% or higher in the outpatient setting. 1 Elderly patients with GERD can clinically present differently than younger patients and their management may therefore vary. A review article published by Dr M Kurin of the Digestive ...
News Archive - Gastroenterology Advisor
Oct 11, 2024 · Clarithromycin administered via a dispersible tablet has a higher Helicobacter pylori (H pylori) eradication rate than clarithromycin sustained-release tablets, according to study results published in Therapeutic Advances in Gastroenterology.
Upper GI Tract Disorders Treated With P-CABs: AGA Clinical …
Oct 25, 2024 · The American Gastroenterological Association (AGA) has released a clinical practice update for managing upper gastrointestinal (GI) tract disorders with potassium-competitive acid blockers (P-CABs).
Chronic Idiopathic Constipation: 10 Recommendations for …
Jun 9, 2023 · The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) have jointly developed a clinical practice guideline regarding the pharmacological management of patients with chronic idiopathic constipation (CIC), as published in the American Journal of Gastroenterology and Gastroenterology.. The guideline provides 10 evidence-based recommendations for ...